Chindex Signs Amended Merger Agreement with TPG and Fosun Pharma; Increases Consideration from $19.50 to $24.00 per Share in Cash; Total Consideration Boosted From $369M to $461M

By: via Benzinga
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company"), an American healthcare company providing services in China ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.